These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1634 related items for PubMed ID: 26149637

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin.
    Calò B, Falagario U, Sanguedolce F, Veccia A, Chirico M, Carvalho-Diaz E, Mota P, Lima E, Autorino R, Carrieri G, Cormio L.
    World J Urol; 2020 Dec; 38(12):3161-3167. PubMed ID: 32062805
    [Abstract] [Full Text] [Related]

  • 3. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR, Sylvester RJ, Brausi MA, Kirkels WJ, van de Beek C, van Andel G, de Reijke TM, Prescott S, Witjes JA, Oosterlinck W.
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [Abstract] [Full Text] [Related]

  • 4. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M, Olaru V.
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B, Değirmenci T, Arslan M, Nergiz N, Minareci S, Ayder AR.
    Urol Int; 2005 Dec; 75(2):107-13. PubMed ID: 16123562
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R, Gentile BC, Mirabile G, Albanesi L, Tariciotti P, Rizzo G, Buscarini M, Vermiglio M.
    Arch Ital Urol Androl; 2017 Dec 31; 89(4):272-276. PubMed ID: 29473376
    [Abstract] [Full Text] [Related]

  • 14. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M, Stotz N, Rassweiler J.
    J Endourol; 2007 Dec 31; 21(12):1533-41. PubMed ID: 18186695
    [Abstract] [Full Text] [Related]

  • 15. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun 31; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conservative treatment of high grade superficial bladder tumours.
    Trinchieri A, Bonacina P, Butti A, Cappoli S, Esposito N, Invernizzi S, Librizzi A, Locatelli G.
    Arch Ital Urol Androl; 2005 Dec 31; 77(4):215-8. PubMed ID: 16444936
    [Abstract] [Full Text] [Related]

  • 19. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.
    J Urol; 2003 Jun 31; 169(6):2110-2. PubMed ID: 12771729
    [Abstract] [Full Text] [Related]

  • 20. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J, Sylvester RJ, Faba OR, Parada R, Peña JA, Algaba F, Villavicencio H.
    Eur Urol; 2012 Jul 31; 62(1):118-25. PubMed ID: 22101115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.